Close

Bright Health Group (BHG) Continues to Make Significant Progress Towards ACA Insurance Business Wind-Down Sep 19, 2023 06:45AM
Form SC 13D/A Bright Health Group Inc. Filed by: New Enterprise Associates 15, L.P. Aug 21, 2023 02:34PM
Ikena Oncology (IKNA) Acquires Pionyr Immunotherapeutics in All-Stock Transaction Aug 7, 2023 07:16AM
Form 4 Sagimet Biosciences Inc. For: Jul 18 Filed by: NEW ENTERPRISE ASSOCIATES 13 LP Jul 20, 2023 06:57PM
Gossamer Bio Inc. (GOSS) Announces $212M Private Placement Financing Jul 20, 2023 07:58AM
View Older Stories

Jul 13, 2023 07:01AM Savara (SVRA) Prices 21M Share Offering at $3/sh
Jul 7, 2023 06:01AM Form SC 13D/A MINERVA SURGICAL INC Filed by: NEW ENTERPRISE ASSOCIATES 13 LP
Jun 23, 2023 04:00PM Mirati Therapeutics (MRTX) Appoints Industry Veteran Carol Gallagher, Pharm.D. as New Independent Director
Jun 23, 2023 02:33PM Form SC 13D/A Mirum Pharmaceuticals, Filed by: New Enterprise Associates 16, L.P.
Jun 23, 2023 02:32PM Form SC 13D/A Arcellx, Inc. Filed by: New Enterprise Associates 15, L.P.
Jun 15, 2023 04:23PM Form 4 Mirum Pharmaceuticals, For: Jun 13 Filed by: New Enterprise Associates 16, L.P.
Jun 9, 2023 02:10PM Form SC 13D/A IonQ, Inc. Filed by: New Enterprise Associates 15, L.P.
May 16, 2023 08:31AM X4 Pharmaceuticals (XFOR) Announces $65 Million Private Placement of Common Stock, Warrants
Apr 26, 2023 08:32AM Concerned Shareholders of Cano Health (CANO) Issue Open Letter Regarding the Board’s Entrenchment Maneuvers and Latest Governance Failures
Apr 13, 2023 08:01AM Regulus Therapeutics (RGLS) Announces $15M Private Placement
Apr 10, 2023 04:10PM Form SC 13D/A Berkshire Grey, Inc. Filed by: New Enterprise Associates 15, L.P.
Mar 30, 2023 05:14PM Form SC 13D/A Adaptimmune Therapeutics Filed by: New Enterprise Associates 14, L.P.
Mar 29, 2023 06:05AM Form SC 13D/A RHYTHM PHARMACEUTICALS, Filed by: NEW ENTERPRISE ASSOCIATES 13 LP
Mar 23, 2023 06:30AM Gilead Sciences (GILD) and Pionyr Immunotherapeutics Change Exclusive Option Agreement
Feb 21, 2023 04:42PM Form SC 13D/A MINERVA SURGICAL INC Filed by: NEW ENTERPRISE ASSOCIATES 13 LP
Feb 10, 2023 05:23PM Form SC 13D/A GLYCOMIMETICS INC Filed by: NEW ENTERPRISE ASSOCIATES 10 L P
Feb 3, 2023 05:27PM Form SC 13G/A Tuya Inc. Filed by: New Enterprise Associates 14, L.P.
Jan 24, 2023 04:22PM Form SC 13D/A Arcellx, Inc. Filed by: New Enterprise Associates 15, L.P.
Jan 24, 2023 04:04PM Form SC 13D/A MINERVA SURGICAL INC Filed by: NEW ENTERPRISE ASSOCIATES 13 LP
Jan 9, 2023 04:33PM Form SC 13D/A Oyster Point Pharma, Filed by: New Enterprise Associates 14, L.P.
Dec 28, 2022 06:00AM Minerva Surgical (UTRS) Prices 146.63M Share Private Placement at $0.205/sh
Dec 22, 2022 06:13PM Form 4 Arcellx, Inc. For: Dec 20 Filed by: New Enterprise Associates 15, L.P.
Dec 12, 2022 05:25PM Form SC 13D/A Eargo, Inc. Filed by: New Enterprise Associates 15, L.P.
Dec 12, 2022 08:05AM Black Diamond Therapeutics (BDTX) Announces Spinout of Launchpad Therapeutics, Inc., an Antibody-Focused Precision Oncology Company
Dec 12, 2022 07:31AM Lumos Pharma, Inc. (LUMO) Announces KOL Review of Interim Phase 2 Data Supports Potential for New Oral Therapeutic Paradigm for Moderate Idiopathic PGHD Patients
Nov 21, 2022 01:29PM Form SC 13D/A Oyster Point Pharma, Filed by: New Enterprise Associates 14, L.P.
Nov 18, 2022 05:03PM Form 4 IonQ, Inc. For: Nov 16 Filed by: New Enterprise Associates 15, L.P.
Nov 14, 2022 06:02AM Lumos Pharma (LUMO) Reports Encouraging Interim Results from Two Phase 2 Trials of Oral LUM-201
Nov 4, 2022 04:43PM Form SC 13D/A PhaseBio Pharmaceuticals Filed by: NEW ENTERPRISE ASSOCIATES 13 LP
Nov 4, 2022 08:02AM PMV Pharmaceuticals (PMVP) Appoints Carol Gallagher to its Board
Oct 28, 2022 04:49PM Form SC 13D/A Akouos, Inc. Filed by: New Enterprise Associates 16, L.P.
Oct 26, 2022 04:42PM Form 4 PhaseBio Pharmaceuticals For: Oct 25 Filed by: NEW ENTERPRISE ASSOCIATES 13 LP
Oct 21, 2022 04:42PM Form 4 AVEO PHARMACEUTICALS, For: Oct 19 Filed by: New Enterprise Associates 15, L.P.
Oct 21, 2022 06:01AM Form SC 13D/A Bright Health Group Inc. Filed by: New Enterprise Associates 15, L.P.
Oct 11, 2022 02:02PM Form SC 13D Allakos Inc. Filed by: New Enterprise Associates 16, L.P.
Sep 19, 2022 07:00AM Allakos (ALLK) Prices 29.88M Share Offering at $5.02/sh
Aug 24, 2022 04:01PM Alnylam Pharma (ALNY) Appoints Elliott Sigal to its Board
Aug 16, 2022 07:30AM Lumos Pharma, Inc. (LUMO) Announces $3M Share Buyback
Aug 12, 2022 05:17PM Form SC 13D ZeroFox Holdings, Inc. Filed by: New Enterprise Associates 14, L.P.
Jul 15, 2022 05:25PM Form SC 13D Senti Biosciences, Inc. Filed by: New Enterprise Associates 15, L.P.
Jul 13, 2022 07:15AM Gossamer Bio Inc. (GOSS) Announces $120 Million Private Placement Financing
Jul 1, 2022 05:49AM X4 Pharmaceuticals (XFOR) Announces 50.93M Share Private Placement at $1.095
Jun 6, 2022 05:29PM Form SC 13D/A IonQ, Inc. Filed by: New Enterprise Associates 15, L.P.
May 27, 2022 04:59PM Form SC 13D/A GENOCEA BIOSCIENCES, Filed by: New Enterprise Associates 16, L.P.
May 24, 2022 05:12PM Form SC 13D/A IMARA Inc. Filed by: New Enterprise Associates 14, L.P.
May 16, 2022 07:03AM Celcuity (CELC) Announces $100M Private Placement
May 5, 2022 04:08PM Form SC 13D/A Nkarta, Inc. Filed by: New Enterprise Associates 15, L.P.
May 5, 2022 04:05PM Form SC 13D/A Robinhood Markets, Inc. Filed by: New Enterprise Associates 15, L.P.
May 5, 2022 09:01AM Lumos Pharma, Inc. (LUMO) Enters Collaboration with Massachusetts General Hospital to Evaluate LUM-201
May 4, 2022 07:37PM Form 4 Robinhood Markets, Inc. For: May 02 Filed by: New Enterprise Associates 17, L.P.
View Older Stories